claim: the university of liverpool have developed an online database for checking drug-drug interactions with the experimental covid-19 specific medicinal products
evidence_1: according to the liverpool data, some of the riskiest drug-drug interactions are between experimental covid-19 treatments and heart-related medications, including antiarrhythmics, beta blockers, anti-coagulants, calcium channel blockers, some hypertensives, and lipid-lowering statins.", "on the other hand, the liverpool interactions group has provided prescribing resources where they categorized the interactions of experimental covid-19 antiviral therapies as contraindicated medications, potential interactions requiring dose adjustment/close monitoring, potential interactions of weak intensity or no clinically significant interactions (university of liverpool, 2020)."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )